Authors:
Kleiner, HE
Vulimiri, SV
Miller, L
Johnson, WH
Whitman, CP
DiGiovanni, J
Citation: He. Kleiner et al., Oral administration of naturally occurring coumarins leads to altered phase I and II enzyme activities and reduced DNA adduct formation by polycyclicaromatic hydrocarbons in various tissues of SENCAR mice, CARCINOGENE, 22(1), 2001, pp. 73-82
Authors:
Czerwinski, RM
Harris, TK
Massiah, MA
Mildvan, AS
Whitman, CP
Citation: Rm. Czerwinski et al., The structural basis for the perturbed pK(a) of the catalytic base in 4-oxalocrotonate tautomerase: Kinetic and structural effects of mutations of Phe-50, BIOCHEM, 40(7), 2001, pp. 1984-1995
Authors:
Stanley, TM
Johnson, WH
Burks, EA
Whitman, CP
Citation: Tm. Stanley et al., Expression and stereochemical and isotope effect studies of active 4-oxalocrotonate decarboxylase, BIOCHEM, 39(4), 2000, pp. 718-726
Authors:
Stamps, SL
Taylor, AB
Wang, SC
Hackert, ML
Whitman, CP
Citation: Sl. Stamps et al., Mechanism of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor: Properties of the P1G, P1A, Y95F, and N97A mutants, BIOCHEM, 39(32), 2000, pp. 9671-9678
Authors:
Stanley, TM
Johnson, WH
Burks, EA
Whitman, CP
Hwang, CC
Cook, PF
Citation: Tm. Stanley et al., Expression and stereochemical and isotope effect studies of active 4-oxalocrotonate decarboxylase (vol 39, pg 718, 2000), BIOCHEM, 39(12), 2000, pp. 3514-3514
Citation: Wh. Johnson et al., A kinetic and stereochemical investigation of the role of lysine-32 in thephenylpyruvate tautomerase activity catalyzed by macrophage migration inhibitory factor, BIOCHEM, 38(48), 1999, pp. 16024-16033
Authors:
Hermanowski-Vosatka, A
Mundt, SS
Ayala, JM
Goyal, S
Hanlon, WA
Czerwinski, RM
Wright, SD
Whitman, CP
Citation: A. Hermanowski-vosatka et al., Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration, BIOCHEM, 38(39), 1999, pp. 12841-12849
Authors:
Harris, TK
Czerwinski, RM
Johnson, WH
Legler, PM
Abeygunawardana, C
Massiah, MA
Stivers, JT
Whitman, CP
Mildvan, AS
Citation: Tk. Harris et al., Kinetic, stereochemical, and structural effects of mutations of the activesite arginine residues in 4-oxalocrotonate tautomerase, BIOCHEM, 38(38), 1999, pp. 12343-12357
Authors:
Czerwinski, RM
Harris, TK
Johnson, WH
Legler, PM
Stivers, JT
Mildvan, AS
Whitman, CP
Citation: Rm. Czerwinski et al., Effects of mutations of the active site arginine residues in 4-oxalocrotonate tautomerase on the pK(a) values of active site residues and on the pH dependence of catalysis, BIOCHEM, 38(38), 1999, pp. 12358-12366
Authors:
Taylor, AB
Johnson, WH
Czerwinski, RM
Li, HS
Hackert, ML
Whitman, CP
Citation: Ab. Taylor et al., Crystal structure of macrophage migration inhibitory factor-complexed with(E)-2-fluoro-p-bydroxycinnamate at 1.8 angstrom resolution: Implications for enzymatic catalysis and inhibition, BIOCHEM, 38(23), 1999, pp. 7444-7452
Citation: G. Gadda et al., Characterization of 2-oxo-3-pentynoate as an active-site-directed inactivator of flavoprotein oxidases: Identification of active-site peptides in tryptophan 2-monooxygenase, BIOCHEM, 38(18), 1999, pp. 5822-5828